- Home
- TMO vs AZN Comparison
TMO vs AZN Comparison
Compare TMO & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMO
- AZN
- Stock Information
- Founded
- TMO 1956
- AZN 1992
- Country
- TMO United States
- AZN United Kingdom
- Employees
- TMO N/A
- AZN N/A
- Industry
- TMO Industrial Machinery/Components
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- TMO Industrials
- AZN Health Care
- Exchange
- TMO Nasdaq
- AZN Nasdaq
- Market Cap
- TMO 211.0B
- AZN 234.5B
- IPO Year
- TMO N/A
- AZN 1993
- Fundamental
- Price
- TMO $501.50
- AZN $63.39
- Analyst Decision
- TMO Strong Buy
- AZN Buy
- Analyst Count
- TMO 19
- AZN 9
- Target Price
- TMO $651.56
- AZN $88.80
- AVG Volume (30 Days)
- TMO 1.6M
- AZN 7.5M
- Earning Date
- TMO 10-23-2024
- AZN 11-12-2024
- Dividend Yield
- TMO 0.31%
- AZN 2.34%
- EPS Growth
- TMO 4.56
- AZN 9.79
- EPS
- TMO 15.95
- AZN 4.15
- Revenue
- TMO $42,370,000,000.00
- AZN $51,206,000,000.00
- Revenue This Year
- TMO $0.84
- AZN $17.69
- Revenue Next Year
- TMO $5.38
- AZN $7.95
- P/E Ratio
- TMO $31.44
- AZN $29.92
- Revenue Growth
- TMO N/A
- AZN 13.81
- 52 Week Low
- TMO $465.90
- AZN $60.47
- 52 Week High
- TMO $627.88
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- TMO 18.44
- AZN 20.49
- Support Level
- TMO $549.20
- AZN $62.94
- Resistance Level
- TMO $570.20
- AZN $65.98
- Average True Range (ATR)
- TMO 11.76
- AZN 1.39
- MACD
- TMO -3.63
- AZN -0.35
- Stochastic Oscillator
- TMO 4.04
- AZN 5.68
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.